Pharmaceutical marketers have to work under a stringent regulatory framework, especially for promoting products and services to Physicians.
Many a times regulations are misunderstood and misinterpreted by organizations and marketers, making them averse to any kind of innovation in communication and marketing. While at the other times, marketers unknowingly trespass regulations and they are then taken to task, killing the scope of any further innovation.
This is even more relevant today when there are so many avenues for ethical promotion of brands in a new connected digital world.
Our upcoming 2nd webinar - Digital Marketing & Regulatory: Can They Co-exist in a Regulated Pharma Market - aims at ethical promotion of Pharmaceutical brands to Physicians in a digital framework and addresses issues that marketers are struggling with.
It will bring forth for discussion 3 different perspectives - perspective of law, perspective of an organization and its regulations organization, and perspective of a marketer to drive clarity on the much-debated subject.
Law with regard to digital brand promotion by Pharma companies, especially after COVID-19, is likely to change and you will find more holistic regulation soon. Necessity is the mother of invention and at a time where every free logical individual think it is important to be able to communicate digitally.
